Abel Hall LLC’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$100K Buy
11,727
+498
+4% +$3.27K 0.02% 778
2026
Q2
$64K Buy
11,229
+168
+2% +$726 0.01% 880
2026
Q1
$42.8K Buy
11,061
+533
+5% +$2.19K 0.01% 755
2025
Q4
$44K Buy
+10,528
New +$40.7K 0.01% 668

Other funds holding PGEN

Abel Hall LLC's PGEN Position: Q3 2026 in Review

Abel Hall LLC increased its Precigen (PGEN) stake by 4.4% in Q3 2026, buying an estimated $3.27K and bringing the position to 11,727 shares worth $100K. The position accounts for 0.02% of the portfolio, ranked #778.

Abel Hall LLC first reported a position in PGEN in Q4 2025 and has held it in 4 quarters since. 60 funds tracked by Wall St. Rank hold PGEN as of Q3 2026.

  • Abel Hall LLC held 11,727 shares of Precigen worth $100K as of Q3 2026.
  • Abel Hall LLC bought 498 Precigen shares in Q3 2026, an estimated $3.27K.
  • Precigen made up 0.02% of Abel Hall LLC's portfolio in Q3 2026, its #778 holding.
  • Abel Hall LLC first reported a position in Precigen in Q4 2025 and has held it in 4 quarters since.
  • 60 funds tracked by Wall St. Rank held Precigen as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.